全文获取类型
收费全文 | 2292篇 |
免费 | 145篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 176篇 |
妇产科学 | 28篇 |
基础医学 | 271篇 |
口腔科学 | 51篇 |
临床医学 | 197篇 |
内科学 | 564篇 |
皮肤病学 | 39篇 |
神经病学 | 100篇 |
特种医学 | 482篇 |
外科学 | 185篇 |
综合类 | 29篇 |
预防医学 | 78篇 |
眼科学 | 25篇 |
药学 | 115篇 |
中国医学 | 4篇 |
肿瘤学 | 109篇 |
出版年
2022年 | 16篇 |
2021年 | 28篇 |
2020年 | 26篇 |
2019年 | 14篇 |
2018年 | 39篇 |
2017年 | 17篇 |
2016年 | 38篇 |
2015年 | 44篇 |
2014年 | 50篇 |
2013年 | 80篇 |
2012年 | 59篇 |
2011年 | 55篇 |
2010年 | 97篇 |
2009年 | 74篇 |
2008年 | 62篇 |
2007年 | 59篇 |
2006年 | 55篇 |
2005年 | 54篇 |
2004年 | 41篇 |
2003年 | 30篇 |
2002年 | 42篇 |
2001年 | 34篇 |
2000年 | 46篇 |
1999年 | 39篇 |
1998年 | 138篇 |
1997年 | 123篇 |
1996年 | 128篇 |
1995年 | 98篇 |
1994年 | 78篇 |
1993年 | 84篇 |
1992年 | 40篇 |
1991年 | 34篇 |
1990年 | 28篇 |
1989年 | 72篇 |
1988年 | 50篇 |
1987年 | 65篇 |
1986年 | 48篇 |
1985年 | 58篇 |
1984年 | 29篇 |
1983年 | 35篇 |
1982年 | 34篇 |
1981年 | 27篇 |
1980年 | 38篇 |
1979年 | 17篇 |
1978年 | 17篇 |
1977年 | 23篇 |
1976年 | 30篇 |
1975年 | 33篇 |
1971年 | 7篇 |
1966年 | 5篇 |
排序方式: 共有2459条查询结果,搜索用时 15 毫秒
1.
A M Cesura M D Galva R Imhof E Kyburz G B Picotti M Da Prada 《European journal of pharmacology》1989,162(3):457-465
This study demonstrated the existence of specific binding sites for [3H]Ro 19-6327 in human platelet membranes. This compound is a novel, time-dependent inhibitor of monoamine oxidase type B (MAO-B) and is structurally closely related to [3H]Ro 16-6491. The density of the sites labelled with high affinity by [3H]Ro 19-6327 was similar to that observed in previous studies with [3H]Ro 16-6491 as ligand. Binding was reversible at 20 degrees C and showed a relatively slow dissociation (t1/2 = 220 min). The dissociation rate was markedly decreased (t1/2 = greater than 24h) at 0 degrees C. MAO-B, but not MAO-A inhibitors, effectively prevented the binding of [3H]Ro 19-6327. Like [3H]Ro 16-6491, [3H]Ro 19-6327 is recognized as a substrate by MAO-B, being eventually deaminated by the enzyme. Since the deaminated aldehyde derivative of Ro 19-6327 did not inhibit MAO-B, a still unidentified reversible adduct, formed at the MAO-B active site, might explain the high potency and selectivity of [3H]Ro 19-6327. Incubation of the radioligand-enzyme complex from platelet and brain membranes with NaBH3CN and acetic acid (to pH 4.5) caused the irreversible incorporation of the radioactivity into a single polypeptide as shown by SDS-PAGE analysis. This polypeptide had a molecular weight identical to that of the MAO-B subunit, i.e. 58,000. The presence of unlabelled MAO-B inhibitors in the incubation mixture prevented the covalent incorporation of [3H]Ro 19-6327. The irreversible MAO-B inhibitor, [3H] pargyline, labelled a protein with a molecular weight identical to the protein labelled by [3H]Ro 19-6327.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
2.
JA HYEON KU CHEOL KWAK SEUNG-JUNE OH EUNSIK LEE SANG EUN LEE JAE-SEUNG PAICK 《International journal of urology》2004,11(7):489-493
BACKGROUND: Our aims in the present study were to estimate the influences of pain and urinary symptoms on quality of life, and to determine which of these two variables has the most predictive power with respect to quality of life in young men with chronic prostatitis-like symptoms. METHODS: Chronic prostatitis-like symptoms were measured by the National Institutes of Health-Chronic Prostatitis Symptom Index. Of the 28,841 men aged 20 years who lived in the study community, 18,495 men (a response rate 64.1%) agreed to participate in the study. A total of 1057 men who complained of symptoms indicative of chronic prostatitis were included in the study. The influences of pain and urinary symptoms on quality of life were determined using logistic regression analysis. The receiver operating characteristic (ROC) curve was used to estimate the predictive ability of each of these variables with respect to quality of life. RESULTS: Results from multivariate analysis showed that both pain and urinary symptoms were associated with an increased likelihood of impaired quality of life, although pain contributed more to a reduced quality of life than urinary symptoms. Relative to men who experienced mild pain, men who experienced moderate pain had a 3.9-fold risk of poor quality of life (odds ratio [OR], 3.87; 95% confidence interval [CI], 2.86-5.23; P < 0.001) and those who experienced severe pain had a 15.7-fold risk of reduced quality of life (OR, 15.68; 95% CI, 6.59-37.35; P < 0.001). Moderate urinary symptoms were associated with a 1.4-fold risk of bother (OR, 1.41; 95% CI, 1.01-1.99; P < 0.001) and severe urinary symptoms were associated with 2.4-fold risk (OR, 2.39; 95% CI, 1.37-4.12; P < 0.001), relative to mild urinary symptoms. Comparison of the effects of pain and urinary symptoms showed that pain severity had the most predictive power for bother, quality of life, and quality-of-life impact. The areas under the ROC curves for bother, quality of life, and quality-of-life impact were 71.3%, 69.3% and 72.5%, respectively. CONCLUSION: Urinary symptoms and pain might be associated with an increased likelihood of impaired quality of life in young men with chronic prostatitis-like symptoms. In addition, our findings suggest that pain severity is the most influential variable for determining quality of life in this population. 相似文献
3.
Megakaryocytic Progenitors Can Be Generated Ex Vivo and Safely Administered to Autologous Peripheral Blood Progenitor Cell Transplant Recipients 总被引:9,自引:1,他引:8
4.
5.
6.
7.
8.
9.
10.